But to limit this to only 3 awardees (‘the rule of three’) does not fully recognise the many more scientific giants who have contributed significantly to these breakthrough discoveries.
Further
information
肿瘤前沿
无论采用哪种免疫治疗方案,如果没有充足的T细胞能够识别某种肿瘤,就需要加入作用于第一步的疗法。
Further
information
第一现场
IDO疫苗不仅缓解了IDO介导的免疫抑制,还削弱了IDO阳性细胞介导的普通免疫抑制作用。
Further
information
肿瘤前沿
Primum Non Nocere – First, Do No Harm.
Further
information
肿瘤前沿
肝癌战役中新的白衣骑士将来自于活跃的抗肿瘤免疫领域。肝癌治疗的变革终将在这里发生。
Further
information
肿瘤前沿